Rafferty Asset Management, LLC Oric Pharmaceuticals, Inc. Transaction History
Rafferty Asset Management, LLC
- $27.6 Billion
- Q4 2024
A detailed history of Rafferty Asset Management, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 51,392 shares of ORIC stock, worth $262,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,392
Previous 64,585
20.43%
Holding current value
$262,613
Previous $661,000
37.37%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ORIC
# of Institutions
130Shares Held
67.1MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$27 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$24.7 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$22.6 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$22.5 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$19.9 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $202M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...